NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Medline Inc. MDLN
3 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$28.4B
▲ 11.5% vs FY2024
EPS · FY25
$0.01
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
10.8%
Net margin · FY25
4.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 28.4B
Revenue, FY2025 · full 3-year series below
Revenue
Net income
4 cents of every revenue dollar became profit this year.
Per share
USD 0.01
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
10.8%
Return on equity, FY2025
ROE
Operating margin7.8%
Net margin4.1%
Return on assets3.1%
Each USD of equity produced 11 cents of profit this year.
Returned to shareholders
USD 33.0M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 33.0M
Share of profit2.8%
Consecutive raises—
USD 33.0M in buybacks — 3% of the year's profit went back to shareholders.
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 38.5B
total assets, end of FY2025
Total assetsUSD 38.5B
EquityUSD 10.7B
CashUSD 1.9B
Gross debtUSD 12.6B
Net debtUSD 10.6B
Current ratio4.29×
Net debt stands at 99% of equity.
History
3 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
Revenue $B
28.4
25.5
23.2
Operating income $B
2.2
2.1
1.2
EBITDA $B
3.2
3.1
2.2
Income tax $B
0.1
0.0
0.0
Net income $B
1.2
1.2
0.2
EPS, diluted $
0.01
·
·
Dividend / sh $
·
·
·
Payout %
·
·
·
ROE %
10.8
·
·
Shares out B
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
8 of 8
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed